Cassano A - Search Results

1

Treatment Options for EGFR T790M-Negative EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.

Corallo S, D'Argento E, Strippoli A, Basso M, Monterisi S, Rossi S, Cassano A, Barone CM. Corallo S, et al. Among authors: cassano a. Target Oncol. 2017 Apr;12(2):153-161. doi: 10.1007/s11523-017-0479-4. Target Oncol. 2017. PMID: 28188446 Review.

2

A survey of therapy for advanced renal cell carcinoma.

Basso M, Cassano A, Barone C. Basso M, et al. Among authors: cassano a. Urol Oncol. 2010 Mar-Apr;28(2):121-33. doi: 10.1016/j.urolonc.2009.04.015. Epub 2009 Jul 3. Urol Oncol. 2010. PMID: 19576800 Review.

3

Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis.

Rossi S, D'Argento E, Basso M, Strippoli A, Dadduzio V, Cerchiaro E, Martini M, Cassano A, Barone C. Rossi S, et al. Among authors: cassano a. Mol Diagn Ther. 2016 Feb;20(1):55-63. doi: 10.1007/s40291-015-0176-x. Mol Diagn Ther. 2016. PMID: 26645830

4

Are TKIs favourable for the elderly with non-small-cell lung cancer?

Rossi S, D'Argento E, Schinzari G, Dadduzio V, Di Noia V, Cassano A, Barone C. Rossi S, et al. Among authors: cassano a. Oncotarget. 2016 Jul 26;7(30):46871-46877. doi: 10.18632/oncotarget.9389. Oncotarget. 2016. PMID: 27206674 Free PMC article.

5

From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer?

D'Argento E, Rossi S, Schinzari G, Strippoli A, Basso M, Cassano A, Barone C. D'Argento E, et al. Among authors: cassano a. Curr Treat Options Oncol. 2016 Dec;17(12):59. doi: 10.1007/s11864-016-0437-x. Curr Treat Options Oncol. 2016. PMID: 27766545 Review.

6

Does sarcopenia affect outcome in patients with non-small-cell lung cancer harboring EGFR mutations?

Rossi S, Di Noia V, Tonetti L, Strippoli A, Basso M, Schinzari G, Cassano A, Leone A, Barone C, D'Argento E. Rossi S, et al. Among authors: cassano a. Future Oncol. 2018 Apr;14(10):919-926. doi: 10.2217/fon-2017-0499. Epub 2018 Mar 12. Future Oncol. 2018. PMID: 29528255

7

Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer.

Barone C, Basso M, Schinzari G, Pozzo C, Trigila N, D'Argento E, Quirino M, Astone A, Cassano A. Barone C, et al. Among authors: cassano a. Gastric Cancer. 2007;10(2):104-11. doi: 10.1007/s10120-007-0415-x. Epub 2007 Jun 25. Gastric Cancer. 2007. PMID: 17577620 Clinical Trial.

8

Hormone Receptor Status and HER2 Expression in Primary Breast Cancer Compared With Synchronous Axillary Metastases or Recurrent Metastatic Disease.

Rossi S, Basso M, Strippoli A, Dadduzio V, Cerchiaro E, Barile R, D'Argento E, Cassano A, Schinzari G, Barone C. Rossi S, et al. Among authors: cassano a. Clin Breast Cancer. 2015 Oct;15(5):307-12. doi: 10.1016/j.clbc.2015.03.010. Epub 2015 Mar 25. Clin Breast Cancer. 2015. PMID: 25922284 Review.

9

KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study.

Dadduzio V, Basso M, Rossi S, Cenci T, Capodimonti S, Strippoli A, Orlandi A, Cerchiaro E, Schinzari G, Cassano A, Martini M, Barone C. Dadduzio V, et al. Among authors: cassano a. Mol Diagn Ther. 2016 Feb;20(1):65-74. doi: 10.1007/s40291-015-0178-8. Mol Diagn Ther. 2016. PMID: 26610798

10

Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review.

Rossi S, Schinzari G, Basso M, Strippoli A, Dadduzio V, D'Argento E, Cassano A, Barone C. Rossi S, et al. Among authors: cassano a. Future Oncol. 2016 May;12(10):1299-307. doi: 10.2217/fon-2015-0065. Epub 2016 Mar 21. Future Oncol. 2016. PMID: 26996100 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

362 results

Search Page

Filters